hotspot -WSS

hotspot

author：hotspot 2025-10-01 02:28:35 - browse：858

Obesity conference attendees with a pink and blue Wegovy sign hanging from the ceiling above. -- obesity coverage from STAT — Wegovy, the obesity drug, was inescapable at the ObesityWeek conference in Dallas. Elaine Chen

DALLAS — Here at ObesityWeek, one of the largest conferences on obesity, Novo Nordisk and Eli Lilly are displaying more than a dozen studies that together carry the message: Our blockbuster weight loss treatments will be worth it for society.

But experts point out that much of this company-funded research does not include the cost of the drugs themselves, which sell at more than $10,000 per year in the U.S. and are meant to be taken indefinitely.

The two major pharmaceutical companies have seen interest skyrocket for their GLP-1-based drugs like Ozempic, Wegovy, and Mounjaro, a new generation of medications that can cut substantial amounts of weight. But insurance plans have been slow to grant wide access to obesity treatments, concerned that the vast amount of people eligible to take them, along with their high price, could lead to significant financial strain.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： Statins reduce cardiovascular risk in people living with HIV

hotspot

WSS

What affirmative action's end means to a medical student

Sophia Smith scores twice for US in in 3

PrEP can help anyone prevent HIV. Why do so few people take it?

Hundreds of thousands march in Israel. Former security chiefs beg Netanyahu to halt legal overhaul

Men with early prostate cancer can safely opt out of treatment

How a key Senate committee is planning to regulate PBMs

Wikipedia

hotspot

entertainment

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

What affirmative action's end means to a medical student

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Skip the lead apron during X

Psychedelics group wrestles with new pharma identity

'Screen and refer' systems are hurting patients

Malaria cases in Florida and Texas: Here’s what you need to know

Charges dismissed against white woman who spat on Black woman during protests in Connecticut

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Dexcom's push to bring CGM to type 2 diabetes patients

entertainment

Drug cartel violence flares in western Mexico after vigilante leader's killing

How to protect coverage of PrEP

Men with early prostate cancer can safely opt out of treatment

UpToDate has a racism problem: Dr. Stanley Goldfarb

Drone hits Crimean ammunition depot as strikes kill, wound civilians and journalists in Ukraine

Severe heat forecast: Where scorching temperatures will persist over the next week

explore

hotspot

Wikipedia

hotspot